It is interesting to see that PIC/S has adopted guidance on “COVID-19 Risk Assessment for Routine On-Site Inspections” (PI 055-1). It entered into force on 15 July 2021. Please follow the following link to the PIC/S website “Publications” https://picscheme.org/en/news to download this document. It was nice to see that the larger suppliers that we have audited already use Covid-19 protocols that are similar to the ones adopted by PIC/S.
Search this website
All topics
- Access to medicines (43)
- Alerts and recalls (7)
- Audits & Inspections (2)
- BPF (1)
- BPSD (2)
- ENABEL (6)
- Falsified and sub-standard medicines (10)
- GSDP (2)
- International (10)
- ITM (1)
- Latin America (1)
- Literature updates (32)
- MQAS (11)
- National regulatory authority (3)
- News (33)
- PAHO (2)
- Podcast (2)
- QA standards (13)
- QCP (11)
- Quality assurance (33)
- Quamed News (253)
- Recruitment (9)
- Research (7)
- Technical visits (2)
- Training (8)
- USAID (5)
- Webinaire (1)
- Webinar (23)
- WHO (28)
